Techniques: New pharmacological perspectives for the leptin receptor

被引:36
作者
Peelman, F
Couturier, C
Dam, J
Zabeau, L
Tavernier, J
Jockers, R
机构
[1] State Univ Ghent VIB, Fac Med & Hlth Sci, Dept Med Prot Res, B-9000 Ghent, Belgium
[2] Inst Cochin, Dept Cell Biol, F-75014 Paris, France
[3] INSERM, U567, F-75014 Paris, France
[4] CNRS, UMR 8104, F-75014 Paris, France
[5] Univ Paris 05, Fac Med Rene Descartes, UMR S 8104, F-75014 Paris, France
关键词
D O I
10.1016/j.tips.2006.02.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The function of leptin, initially confined to its role in energy homeostasis and obesity, has now expanded to the regulation of reproduction, glucose homeostasis, bone formation, wound healing and the immune system. Both stimulation and inhibition of the molecular target of leptin, the leptin receptor (LR), might find applications in disease treatment. Recent advances in the understanding of LR activation mechanisms have led to the design of LR antagonists. Several assays have been developed for the screening and evaluation of LR ligands. Both the extracellular and the intracellular domains of the LR are potential drug targets. The bioluminescence resonance energy transfer technique can be used to screen for compounds that target the extracellular part of the LR, and we propose that the novel reverse mammalian protein-protein interaction trap technique can be used to screen compounds that affect intracellular aspects of LR signalling. These assays can be easily adapted to other pharmacologically relevant receptors.
引用
收藏
页码:218 / 225
页数:8
相关论文
共 60 条
[1]   Leptin signaling [J].
Ahima, RS ;
Osei, SY .
PHYSIOLOGY & BEHAVIOR, 2004, 81 (02) :223-241
[2]   Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers [J].
Ayoub, MA ;
Levoye, A ;
Delagrange, P ;
Jockers, R .
MOLECULAR PHARMACOLOGY, 2004, 66 (02) :312-321
[3]   Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer [J].
Ayoub, MA ;
Couturier, C ;
Lucas-Meunier, E ;
Angers, S ;
Fossier, P ;
Bouvier, M ;
Jockers, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21522-21528
[4]   Activation of downstream signals by the long form of the leptin receptor [J].
Banks, AS ;
Davis, SM ;
Bates, SH ;
Myers, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14563-14572
[5]   The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors [J].
Baumann, H ;
Morella, KK ;
White, DW ;
Dembski, M ;
Bailon, PS ;
Kim, HK ;
Lai, CF ;
Tartaglia, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8374-8378
[6]  
Biener E, 2005, BIOL CELL, V97, P905
[7]   Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer [J].
Blanquart, C ;
Boute, N ;
Lacasa, D ;
Issad, T .
MOLECULAR PHARMACOLOGY, 2005, 68 (03) :885-894
[8]   The use of resonance energy transfer in high-throughput screening: BRET versus FRET [J].
Boute, N ;
Jockers, R ;
Issad, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :351-354
[9]  
Boute N, 2001, MOL PHARMACOL, V60, P640
[10]  
Broekaert D, 2002, EUR CYTOKINE NETW, V13, P78